These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9636466

  • 1. Clinical impact of Neoral in heart transplantation.
    Aziz T, el-Gamel A, Keevil B, Martyszczuk R, Campbell C, Rahman A, Deiraniya A, Yonan N.
    Transplant Proc; 1998 Jun; 30(4):1152-3. PubMed ID: 9636466
    [No Abstract] [Full Text] [Related]

  • 2. Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
    Maccherini M, Bernazzali S, Diciolla F, Giunti G, Bizzarri F, Lisi GF, Davoli G, Biagioli B, Giomarelli PP, Simeone F, Caciorgna M, Marchetti L, Pula G, Sani G, Toscano M.
    Transplant Proc; 1998 Aug; 30(5):1904-5. PubMed ID: 9723327
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conversion from Sandimmune to Neoral in stable liver graft recipients.
    Pollard SG, Lodge JP.
    Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
    [No Abstract] [Full Text] [Related]

  • 6. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R, Sgrosso JL, Sabbatiello R, Castro C, Ahualli L, Pattin M, Vazquez MC.
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract] [Full Text] [Related]

  • 7. Clinical impact of Neoral in thoracic organ transplantation.
    Aziz T, el-Gamel A, Keevil B, Krysiak P, Campbell C, Rahman A, Deiraniya A, Yonan N.
    Transplant Proc; 1998 Aug; 30(5):1900-3. PubMed ID: 9723326
    [No Abstract] [Full Text] [Related]

  • 8. Long-term safety and efficacy of Neoral in heart transplantation.
    Yonan NA, Aziz T, el-Gamel A, Campbell CS, Rahman AN, Deiraniya AK.
    Transplant Proc; 1998 Aug; 30(5):1906-9. PubMed ID: 9723328
    [No Abstract] [Full Text] [Related]

  • 9. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation.
    Heroux AL, LeBlanc MH, Beaudoin D, Simard S, Coulombe DA, Gleeton O, Lemieux MD, Doyle DP.
    Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219
    [No Abstract] [Full Text] [Related]

  • 10. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B, Korn A.
    Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract] [Full Text] [Related]

  • 11. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
    Griffin PJ, Moore RH, Jurewicz WA, Lord RH, Webley Y, Jenkins J.
    Transplant Proc; 1997 Aug; 29(1-2):303. PubMed ID: 9123007
    [No Abstract] [Full Text] [Related]

  • 12. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H, Asmundsson P, Clausen P, Dieperink H, Hansen JM, Heaf J, Jensen SB, Kornerup HJ, Madsen S, Pedersen EB, Poulsen JV, Rasmussen K.
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract] [Full Text] [Related]

  • 13. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C, Laine J, Jalanko H, Leijala M, Hoppu K.
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract] [Full Text] [Related]

  • 14. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
    Cossu M, Satta R, Branca GF, Pala PG, Serra G, Satta RP, Sorba G.
    Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
    [No Abstract] [Full Text] [Related]

  • 15. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.
    Bilbao I, Parrilla P, Rimola A, Figueras J, Fabrega E, Gomez M, De Vicente E, Margarit C.
    Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300
    [No Abstract] [Full Text] [Related]

  • 16. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year.
    Cooney GF, Jeevanandam V, Choudhury S, Feutren G, Mueller EA, Eisen HJ.
    Transplant Proc; 1998 Aug; 30(5):1892-4. PubMed ID: 9723323
    [No Abstract] [Full Text] [Related]

  • 17. Use of cyclosporine MEPC (Neoral) in heart transplant recipients.
    Fukushima N, Ohtake S, Sawa Y, Nishimura M, Kobayashi Y, Shirakura R, Nakata S, Matsuda H.
    Transplant Proc; 1998 Nov; 30(7):3337-8. PubMed ID: 9838473
    [No Abstract] [Full Text] [Related]

  • 18. Neoral-based immunosuppression in living-related donor liver transplantation.
    Liu PP, Chen CL, Chen YS, Wang CC, Chiang YC, Goto S, Cheng YF, Huang TL, Eng HL, Cheung HK, Jawan B.
    Transplant Proc; 1998 Nov; 30(7):3550-1. PubMed ID: 9838554
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [Abstract] [Full Text] [Related]

  • 20. Experience with clinical use of Sandimmun Neoral in renal transplant patients.
    Min ZL, Zhao M, Zhu YH, Qi J, Wang LM, Wang YW.
    Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.